<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 21-year-old woman with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> received an allogeneic bone marrow transplant (allo-BMT) from an HLA-matched and ABO-matched sibling donor after conditioning with <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, rabbit ATG (Lymphoglobuline; Aventis-Pharma), and total lymphoid irradiation </plain></SENT>
<SENT sid="1" pm="."><plain>She had a long history of <z:chebi fb="0" ids="4031">cyclosporin A</z:chebi> (CsA) therapy before conditioning </plain></SENT>
<SENT sid="2" pm="."><plain>She complained of severe <z:hpo ids='HP_0002315'>headache</z:hpo> and <z:mp ids='MP_0000947'>convulsions</z:mp> on day 0, and findings on magnetic resonance images suggested CsA-induced <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>CsA was immediately stopped, and tacrolimus for prevention of <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> (GVHD) was started on day 2 </plain></SENT>
<SENT sid="4" pm="."><plain>Hematological engraftment was observed on day 14 without serious GVHD </plain></SENT>
<SENT sid="5" pm="."><plain>Prompt diagnosis, replacement of <z:chebi fb="1" ids="35705">immunosuppressive agents</z:chebi>, and careful monitoring of serum drug concentrations are thought to have contributed to the patient's good clinical course, since CsA-induced <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> tends to be recurrent but to improve completely without any sequelae </plain></SENT>
</text></document>